CClinicalTrials.gg
RecruitingNCT07408375Pulmojet 3Updated Mar 27, 2026

Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology

An interventional study of High-Frequency Jet Ventilation (HFJV) in Solid Tumor (Excluding CNS), sponsored by Nantes University Hospital. Recruiting at 7 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
560
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that enables tumor ablation under radiological imaging guidance.

This procedure, being less invasive than conventional surgery, allows for a faster recovery and hospital discharge. This procedure requires significant precision to ensure the most complete destruction of the tumor, while also preserving adjacent organs. During general anesthesia, respiratory movements complicate radiological localization and tumor destruction.

The principle of High-Frequency Jet Ventilation (HFJV) involves using a device that ventilates a small volume of air and oxygen at a specific pressure, called driving pressure, at a high frequency.

This ventilation mode reduces respiratory movements while ensuring continuous ventilation and oxygenation. This respiratory stability allows for the precision necessary to superimpose images for tumor localization and destruction.

There are no guidelines regarding the driving pressure setting for HFJV for tumor thermal ablation. The method tested in this research is based on patient's height to optimize the driving pressure when using HFV.

The main objective of this research is to evaluate the impact of driving pressure settings, on respiratory function, taking into account patient's height.

On the day of the procedure, the driving pressure setting for the HFJV will be randomly assigned (1.4 bars, 1.9 bars, 2.4 bars, or customized according to the patient's height) (1 bar = 14 psi).

The research will be conducted using medical data collected during routine patient care. Patient participation will last for the duration of their hospital stay, approximately two days.

Read the detailed description

Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that allows for the destruction of a tumor under radiological imaging guidance.

This procedure, less invasive than conventional surgery, allows for a faster recovery and return home. This procedure requires significant precision to ensure the most complete destruction of the tumor, while also preserving organs near the lesion. During general anesthesia, respiratory movements complicate radiological localization and tumor destruction.

The principle of High-Frequency Jet Ventilation (HFJV) involves using a device that ventilates a small volume of air and oxygen at a specific pressure, called driving pressure, at a high frequency.

This ventilation mode reduces respiratory movements while ensuring continuous ventilation and oxygenation. This respiratory stability allows for the precision necessary to superimpose images for tumor localization and destruction.

There are no recommendations regarding the driving pressure setting for HFJV for tumor thermal ablation. The method tested in this research is based on patient's height to optimize the driving pressure when using HFV.

The main objective of this research is to evaluate the impact of driving pressure settings, on respiratory function, taking into account patient's height.

On the day of the procedure, the driving pressure setting for the HFJV will be randomly assigned (1.4 bars, 1.9 bars, 2.4 bars, or customized according to the patient's height).

The research will be conducted using medical data collected during patient care. Patient participation will last for the duration of their hospital stay, approximately two days.

02

Conditions studied

  • Solid Tumor (Excluding CNS)

Keywords

  • Ventilation
  • High-Frequency Jet Ventilation
  • Anesthesia
  • Interventional Radiology
  • Tumor ablation
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's planned enrollment of 560 is above the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 18 years.
  • Patient undergoing thermal ablation of a solid tumor under HFJV.
  • Patient who has given their consent.
  • Patient covered by a social security scheme.

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship or curatorship.
  • Patient who does not understand French.
  • Pregnant and breastfeeding woman
  • Patient who has had a pneumonectomy
  • Patient requiring an endotracheal tube smaller than 6.5
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
560 participants (estimated)

Study arms

  • Active comparator
    Driving pressure with a fixed setting of 1.4 bars

    On the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.4 bars.

    Procedure: High-Frequency Jet Ventilation (HFJV)

  • Active comparator
    Driving pressure with a fixed setting of 1.9 bars

    On the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.9 bars.

    Procedure: High-Frequency Jet Ventilation (HFJV)

  • Active comparator
    Driving pressure with a fixed setting of 2.4 bars

    On the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 2.4 bars.

    Procedure: High-Frequency Jet Ventilation (HFJV)

  • Experimental
    Driving pressure with a personalized setting

    On the day of the interventional radiology surgery (Day 0), the driving pressure setting will be personalized according to the patient's height : 1.4 bars if patient's height \< 150 cm, 1.6 bars if patient's height is between 150 cm and 160 cm, 1.8 bars if patient's height is between 161 cm and 170 cm, 2.0 bars if patient's height is between 171 cm and 180 cm, 2.2 bars if patient's height is between 181 cm and 190 cm and 2.4 bars if patient's height \> 190 cm

    Procedure: High-Frequency Jet Ventilation (HFJV)

Interventions

  • ProcedureHigh-Frequency Jet Ventilation (HFJV)

    High-Frequency Jet Ventilation (HFJV) involves ventilating with a small tidal volume of gas at a high frequency, ensuring diaphragmatic stability. This stability allows for the precise superimposition of localization and puncture images. HFJV is defined as a ventilation mode with very high insufflation rates (120 to 200 cycles per minute) delivering a low tidal volume through a catheter with a gauge of 13G to 16G.

06

What researchers measure

Primary outcomes

  1. Efficacy on respiratory function of a personalized strategy for adjusting the driving pressure of the HFJV

    Occurrence of at least one of the following events : * Absolute change in FetCO2 of 8 mmHg between the baseline (T0) and the end of HFJV (T1), And/or * FetCO2 ≥ 45 mmHg at the end of the procedure, And/or * SpO2 \< 94% at the end of the procedure, And/or * Interruption of HFJV before the end of the procedure due to SpO2 ≤ 90%.

    Time frame: Immediately after the procedure

Secondary outcomes

  1. Efficiency of the personalized setting compared to a fixed setting of 1.4 bars

    Occurrence of at least one of the four events comprising the main criterion, in the personalized setting group and in the fixed setting group of 1.4 bars

    Time frame: Immediately after the procedure

  2. Efficiency of the personalized setting compared to a fixed setting of 1.9 bars

    Occurrence of at least one of the four events comprising the main criterion, in the personalized setting group and in the fixed setting group of 1.9 bars

    Time frame: Immediately after the procedure

  3. Efficiency of the personalized setting compared to a fixed setting of 2.4 bars

    Occurrence of at least one of the four events comprising the main criterion in the personalized setting group and in the fixed setting group of 2.4 bars

    Time frame: Immediately after the procedure

  4. Efficiency for each of the four events comprising the composite criterion of the customized setting compared to all three other groups

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in all three other groups

    Time frame: Immediately after the procedure

  5. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 1.4 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 1.4 bars

    Time frame: Immediately after the procedure

  6. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 1.9 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 1.9 bars

    Time frame: Immediately after the procedure

  7. Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 2.4 bars

    Occurrence of each of the four events of the composite criterion in the personalized setting group and in the fixed setting group of 2.4 bars

    Time frame: Immediately after the procedure

  8. Risk factors for respiratory complications

    Patient and HFJV intervention characteristics associated with the occurrence of respiratory complications during JVHF at T1

    Time frame: Immediately after the procedure

  9. Oxygen saturation

    Variation in SpO2

    Time frame: Immediately after the procedure

  10. Nu-Desc score

    Change in the Nu-Desc score in the post-anesthesia care unit

    Time frame: At day 0

  11. Patient's surgical pathway

    Duration in post-intervention care unit

    Time frame: From time of randomization until the time of care unit discharge assessed up to one day

  12. Patient journey during the stay

    Duration of stay

    Time frame: From time of randomization until the time of hospital discharge assessed up to one day

  13. Headache

    Occurence of headache in the post-anesthesia care unit

    Time frame: At day 0

  14. Sweating

    Occurence of sweating in the post-anesthesia care unit

    Time frame: At day 0

07

Study locations

2 of 7 sites recruiting
  • CHU de Lyon
    Lyon, 69002, France
    • Stéphanie CLERC · Contact · stephanie.clerc@chu-lyon.fr · 0472118088
    • Stéphanie CLERC · Principal investigator
    • Emma AKA · Sub investigator
    Not yet recruiting
  • Centre Léon Bérard
    Lyon, 69008, France
    Not yet recruiting
  • CHU de Nantes
    Nantes, 44093, France
    Recruiting
  • CHU de Nîmes
    Nîmes, 30900, France
    • Natacha SIMON-MONNIER · Contact · natacha.simon@chu-nimes.fr · 0466686868
    • Natacha SIMON-MONNIER · Principal investigator
    • Danielle GARNIER · Sub investigator
    Not yet recruiting
  • CHU de Poitiers
    Poitiers, 86000, France
    Not yet recruiting
  • ICO Unicancer
    Saint-Herblain, 44800, France
    Not yet recruiting
  • Institut Gustave Roussy
    Villejuif, 94800, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07408375
Lead sponsor
Nantes University Hospital
Responsible party
Sponsor
First posted
Feb 13, 2026
Start date
Mar 13, 2026
Primary completion
Mar 13, 2028 (estimated)
Completion
Mar 13, 2028 (estimated)
Last update
Mar 27, 2026

Study contacts

Nathalie DESFRICHES-DORIA
Contact
nathalie.desfrichesdoria@chu-nantes.fr
0244768434

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion